Triple-Negative Breast Cancer Research and Education Act of 2025

Under Section 3 (adding section 417B(a) of the Public Health Service Act), the Director of the National Institutes of Health is required to expand, intensify, and coordinate research programs for triple-negative breast cancer. This could benefit individuals by leading to a better understanding of how to prevent or cure the disease.

Under Section 3 (adding section 417B(b) of the Public Health Service Act), the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, must develop and disseminate public information regarding triple-negative breast cancer, including its incidence, the elevated risk for minority women, and available treatment options. This is positive because it educates the public and raises awareness about the disease.

Under Section 3 (adding section 417B(c) of the Public Health Service Act), the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, must develop and distribute information to health care providers regarding triple-negative breast cancer, elevated risks for minority women, and treatment options. This could benefit patients by helping ensure their health care providers remain informed with current information.